Literature DB >> 2015886

Ethanol has an acute effect on bile acid biosynthesis in man.

M Axelson1, B Mörk, J Sjövall.   

Abstract

A single dose of ethanol, 0.4 g/kg body weight, was found to give a 5-15 fold increase of the plasma concentrations of 7 alpha-hydroxy-cholesterol and 7 alpha-hydroxy-4-cholesten-3-one in humans. The rise was maximal 4 h after ethanol ingestion, was dose-dependent and was not seen in a cholecystectomized subject. The effect was selective for these and some other 7 alpha-hydroxylated C27-intermediates in bile acid biosynthesis. The changes are compatible with an acute stimulation of cholesterol 7 alpha-hydroxylase possibly due to an ethanol-induced inhibition of gallbladder contraction resulting in an interruption of the enterohepatic circulation of bile acids. The effect is of interest in relation to the influence of ethanol consumption on cardiovascular and gallstone diseases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015886     DOI: 10.1016/0014-5793(91)80382-d

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea.

Authors:  Banny S Wong; Michael Camilleri; Paula Carlson; Sanna McKinzie; Irene Busciglio; Olga Bondar; Roy B Dyer; Jesse Lamsam; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2012-05-18       Impact factor: 11.382

2.  Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.

Authors:  Jason M Ridlon; Dae-Joong Kang; Phillip B Hylemon; Jasmohan S Bajaj
Journal:  Dig Dis       Date:  2015-05-27       Impact factor: 2.404

Review 3.  Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease.

Authors:  Eric K Kwong; Puneet Puri
Journal:  Transl Gastroenterol Hepatol       Date:  2021-01-05

Review 4.  Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives.

Authors:  Juan P Arab; Marco Arrese; Vijay H Shah
Journal:  Hepatol Res       Date:  2020-01-13       Impact factor: 4.288

5.  Publisher Correction: The gut-liver axis and the intersection with the microbiome.

Authors:  Anupriya Tripathi; Justine Debelius; David A Brenner; Michael Karin; Rohit Loomba; Bernd Schnabl; Rob Knight
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-12       Impact factor: 46.802

6.  Fifty years with bile acids and steroids in health and disease.

Authors:  Jan Sjövall
Journal:  Lipids       Date:  2004-08       Impact factor: 1.880

7.  Colonic inflammation and secondary bile acids in alcoholic cirrhosis.

Authors:  Genta Kakiyama; Phillip B Hylemon; Huiping Zhou; William M Pandak; Douglas M Heuman; Dae Joong Kang; Hajime Takei; Hiroshi Nittono; Jason M Ridlon; Michael Fuchs; Emily C Gurley; Yun Wang; Runping Liu; Arun J Sanyal; Patrick M Gillevet; Jasmohan S Bajaj
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-03       Impact factor: 4.052

Review 8.  The gut-liver axis and the intersection with the microbiome.

Authors:  Anupriya Tripathi; Justine Debelius; David A Brenner; Michael Karin; Rohit Loomba; Bernd Schnabl; Rob Knight
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-07       Impact factor: 46.802

9.  Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea.

Authors:  Sanjeev S Pattni; W Gordon Brydon; Tracy Dew; Julian R F Walters
Journal:  Clin Transl Gastroenterol       Date:  2012-07-26       Impact factor: 4.488

Review 10.  Role of farnesoid X receptor and bile acids in alcoholic liver disease.

Authors:  Sharon Manley; Wenxing Ding
Journal:  Acta Pharm Sin B       Date:  2015-03-09       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.